InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by HARRIGAN EDMUND, Director. Director active across 1 companies, notably INCYTE CORP. In total, 11 disclosures have been recorded. The latest transaction was disclosed on 30 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
€17,112236 shares@ €72.50650.0001% mcap13.7% of flow
Common Stock
SEC:0001209191-22-040184:0·
02,144 shares0
Common Stock
SEC:0001209191-22-037798:0·
€17,215240 shares@ €71.72820.0001% mcap13.8% of flow
Common Stock
SEC:0001209191-22-022292:0·
€16,397253 shares@ €64.81220.0001% mcap36.2% of flow
Common Stock
SEC:0001209191-22-000712·
€16,397253 shares@ €64.81220.0001% mcap13.1% of flow
Common Stock
SEC:0001209191-22-000712:0·
€14,083237 shares@ €59.42390.0001% mcap31.1% of flow
Common Stock
SEC:0001209191-21-058993·
€14,083237 shares@ €59.42390.0001% mcap11.3% of flow
Common Stock
SEC:0001209191-21-058993:0·
€14,759208 shares@ €70.95520.0001% mcap32.6% of flow
Common Stock
SEC:0001209191-21-044648·
€14,759208 shares@ €70.95520.0001% mcap11.8% of flow
Common Stock
SEC:0001209191-21-044648:0·
01,923 shares0
Common Stock
SEC:0001209191-21-036407·
01,923 shares0
Common Stock
SEC:0001209191-21-036407:0·
11 of 11 declarations
About HARRIGAN EDMUND
Edmund Harrigan is a Board Member at Incyte Corp. He has extensive experience in the biopharmaceutical sector. His role as a Board Member includes overseeing research and development strategies as well as evaluating market opportunities for the company.
